165 related articles for article (PubMed ID: 36908221)
21. CTNNB1 Mutations and Estrogen Receptor Expression in Neuromuscular Choristoma and Its Associated Fibromatosis.
Carter JM; Howe BM; Hawse JR; Giannini C; Spinner RJ; Fritchie KJ
Am J Surg Pathol; 2016 Oct; 40(10):1368-74. PubMed ID: 27259010
[TBL] [Abstract][Full Text] [Related]
22. Lower Rate of CTNNB1 Mutations and Higher Rate of APC Mutations in Desmoid Fibromatosis of the Breast: A Series of 134 Tumors.
Norkowski E; Masliah-Planchon J; Le Guellec S; Trassard M; Courrèges JB; Charron-Barra C; Terrier P; Bonvalot S; Coindre JM; Laé M
Am J Surg Pathol; 2020 Sep; 44(9):1266-1273. PubMed ID: 32590455
[TBL] [Abstract][Full Text] [Related]
23. Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors.
Lazar AJ; Tuvin D; Hajibashi S; Habeeb S; Bolshakov S; Mayordomo-Aranda E; Warneke CL; Lopez-Terrada D; Pollock RE; Lev D
Am J Pathol; 2008 Nov; 173(5):1518-27. PubMed ID: 18832571
[TBL] [Abstract][Full Text] [Related]
24. The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors).
Lips DJ; Barker N; Clevers H; Hennipman A
Eur J Surg Oncol; 2009 Jan; 35(1):3-10. PubMed ID: 18722078
[TBL] [Abstract][Full Text] [Related]
25. An unusual finding in a desmoid-type fibromatosis of the pancreas: a case report and review of the literature.
Torres JC; Xin C
J Med Case Rep; 2018 May; 12(1):123. PubMed ID: 29751773
[TBL] [Abstract][Full Text] [Related]
26. A germline mutation at the extreme 3' end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor.
Couture J; Mitri A; Lagace R; Smits R; Berk T; Bouchard HL; Fodde R; Alman B; Bapat B
Clin Genet; 2000 Mar; 57(3):205-12. PubMed ID: 10782927
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological features of 70 desmoid-type fibromatoses confirmed by β-catenin immunohistochemical staining and CTNNB1 mutation analysis.
An J; Woo HY; Lee Y; Kim HS; Jeong J; Kim SK
PLoS One; 2021; 16(4):e0250619. PubMed ID: 33914771
[TBL] [Abstract][Full Text] [Related]
28. [Clinicopathologic and genetic studies of desmoid-type fibromatosis].
Yang JL; Wang J; Zhou XY; Li XQ; Hou YY; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2006 Mar; 35(3):145-50. PubMed ID: 16630502
[TBL] [Abstract][Full Text] [Related]
29. A comparison of the usefulness of nuclear beta-catenin in the diagnosis of desmoid-type fibromatosis among commonly used anti-beta-catenin antibodies.
Yamada Y; Hirata M; Sakamoto A; Noguchi T; Ito K; Nishida Y; Matsuda S; Haga H
Pathol Int; 2021 Jun; 71(6):392-399. PubMed ID: 33788979
[TBL] [Abstract][Full Text] [Related]
30. CTNNB1 S45F mutation predicts poor efficacy of meloxicam treatment for desmoid tumors: a pilot study.
Hamada S; Futamura N; Ikuta K; Urakawa H; Kozawa E; Ishiguro N; Nishida Y
PLoS One; 2014; 9(5):e96391. PubMed ID: 24788118
[TBL] [Abstract][Full Text] [Related]
31. Resection of a desmoid-type fibromatosis with a CTNNB1 p.S45P mutation using a cervico-thoracic approach: A case report and literature review.
Sato R; Bandoh N; Goto T; Uemura A; Inoue N; Otomo Y; Nakano H; Yamaguchi T; Kato Y; Nishihara H; Takei H; Harabuchi Y
Auris Nasus Larynx; 2021 Aug; 48(4):777-782. PubMed ID: 32505607
[TBL] [Abstract][Full Text] [Related]
32. Desmoid fibromatosis involving the pancreas: A retrospective case series with clinical, cytopathologic and radiologic correlation.
Clarke-Brodber AL; Hartley CP; Ahmed F; Thangaiah JJ; Tiegs-Heiden C; Hagen CE
Ann Diagn Pathol; 2022 Oct; 60():152015. PubMed ID: 35908332
[TBL] [Abstract][Full Text] [Related]
33. Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis).
Kummar S; O'Sullivan Coyne G; Do KT; Turkbey B; Meltzer PS; Polley E; Choyke PL; Meehan R; Vilimas R; Horneffer Y; Juwara L; Lih A; Choudhary A; Mitchell SA; Helman LJ; Doroshow JH; Chen AP
J Clin Oncol; 2017 May; 35(14):1561-1569. PubMed ID: 28350521
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors in desmoid-type fibromatosis: a clinicopathological and immunohistochemical analysis of 46 cases.
Huang PW; Tzen CY
Pathology; 2010 Feb; 42(2):147-50. PubMed ID: 20085516
[TBL] [Abstract][Full Text] [Related]
35. A novel case of a sporadic desmoid tumour with mutation of the beta catenin gene.
Shitoh K; Konishi F; Iijima T; Ohdaira T; Sakai K; Kanazawa K; Miyaki M
J Clin Pathol; 1999 Sep; 52(9):695-6. PubMed ID: 10655994
[TBL] [Abstract][Full Text] [Related]
36. AKT1 and BRAF mutations in pediatric aggressive fibromatosis.
Meazza C; Belfiore A; Busico A; Settanni G; Paielli N; Cesana L; Ferrari A; Chiaravalli S; Massimino M; Gronchi A; Colombo C; Pilotti S; Perrone F
Cancer Med; 2016 Jun; 5(6):1204-13. PubMed ID: 27062580
[TBL] [Abstract][Full Text] [Related]
37. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).
Alman BA; Li C; Pajerski ME; Diaz-Cano S; Wolfe HJ
Am J Pathol; 1997 Aug; 151(2):329-34. PubMed ID: 9250146
[TBL] [Abstract][Full Text] [Related]
38. Pancreatic desmoid-type fibromatosis with beta-catenin gene mutation-Report of a case and review of the literature.
Tsukamoto Y; Imakita M; Nishitani A; Ito T; Izukura M; Hirota S
Pathol Res Pract; 2016 May; 212(5):484-9. PubMed ID: 26907785
[TBL] [Abstract][Full Text] [Related]
39. Aggressive fibromatosis.
Fisher C; Thway K
Pathology; 2014 Feb; 46(2):135-40. PubMed ID: 24378386
[TBL] [Abstract][Full Text] [Related]
40. Novel intra-genic large deletions of CTNNB1 gene identified in WT desmoid-type fibromatosis.
Colombo C; Urbini M; Astolfi A; Collini P; Indio V; Belfiore A; Paielli N; Perrone F; Tarantino G; Palassini E; Fiore M; Pession A; Stacchiotti S; Pantaleo MA; Gronchi A
Genes Chromosomes Cancer; 2018 Oct; 57(10):495-503. PubMed ID: 29901254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
